EXELLENS Trademark

Trademark Overview


On Wednesday, October 1, 2025, a trademark application was filed for EXELLENS with the United States Patent and Trademark Office. The USPTO has given the EXELLENS trademark a serial number of 99422777. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, May 12, 2026. This trademark is owned by Samsung Biologics Co., Ltd.. The EXELLENS trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

business administration and office work; marketing services; demonstration of goods; import-export agency services; advertising services relating to pharmaceutical products; business advisory services for business in the field of medical services and healthcare; electronic data collection services for business purposes in the pharmaceutical and healthcare fields; providing consumer product information via the Internet; electronic data processing services relating to healthcare information; accounting consultancy services; healthcare cost management services; statistical analysis for research, development, and manufacturing in the field of biopharmaceuticals; data evaluation, and preparation of business reports in the field of biopharmaceutical research

conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; scientific services, namely, toxicity analysis, cell-based toxicity assays, in vitro toxicity testing, bio-safety testing during drug development and manufacturing; scientific research services in the field of conducting clinical trials and supports for others; clinical studies of medicines; services for assessing the efficiency of pharmaceuticals, namely, potency and efficacy testing; analysis and evaluation of medical product development; medical research laboratory services; providing information on the testing, inspection and research of medical products; medicine research; evaluating of clinical trial progress being target group setting and data collection for scientific research purposes; computer programming services in the medical field; multiple nucleic acid analysis; scientific servi...

Custom manufacture of biopharmaceuticals, processing of medicinal materials; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; processing of biopharmaceutical products, namely, raw materials, cell culture, purification, and formulation services; chemical treatment of liquids; custom manufacturing of cell lines for biopharmaceutical production; custom manufacturing of glycosylated pharmaceutical preparations with specific antibody binding
exellens

General Information


Serial Number99422777
Word MarkEXELLENS
Filing DateWednesday, October 1, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, May 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesbusiness administration and office work; marketing services; demonstration of goods; import-export agency services; advertising services relating to pharmaceutical products; business advisory services for business in the field of medical services and healthcare; electronic data collection services for business purposes in the pharmaceutical and healthcare fields; providing consumer product information via the Internet; electronic data processing services relating to healthcare information; accounting consultancy services; healthcare cost management services; statistical analysis for research, development, and manufacturing in the field of biopharmaceuticals; data evaluation, and preparation of business reports in the field of biopharmaceutical research
Goods and Servicesconducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; scientific services, namely, toxicity analysis, cell-based toxicity assays, in vitro toxicity testing, bio-safety testing during drug development and manufacturing; scientific research services in the field of conducting clinical trials and supports for others; clinical studies of medicines; services for assessing the efficiency of pharmaceuticals, namely, potency and efficacy testing; analysis and evaluation of medical product development; medical research laboratory services; providing information on the testing, inspection and research of medical products; medicine research; evaluating of clinical trial progress being target group setting and data collection for scientific research purposes; computer programming services in the medical field; multiple nucleic acid analysis; scientific services being protein analysis for IPC, namely, release, stability testing, compendial testing, protein concentration, chemical/biochemical testing, protein characterization, and quantification; biotechnological research; genetic research, namely, gene expression analysis; scientific research; scientific molecular analysis services, namely, DNA and RNA analysis; research in the field of food; development in the field of biotechnology; biochemical analysis services; scientific research in the field of genetics and genetic engineering; biochemical research; cell culture services for scientific research purposes for others; biological analysis, namely, IPC (In-Process Control), release, and stability testing such as cell-based assays and binding ELISA (Enzyme-Linked Immunosorbent Assay), and biomarker analysis of biological samples; biological research; research of biologics; development of pharmaceutical preparations and medicines; scientific laboratory services for high-throughput glycan analysis; biological research and analysis relating to glycosylation profiling; technical support services for computer software in the nature of development and manufacturing process optimization/simulation, trend analysis, and risk management relating to handling of medical imaging data
Goods and ServicesCustom manufacture of biopharmaceuticals, processing of medicinal materials; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; processing of biopharmaceutical products, namely, raw materials, cell culture, purification, and formulation services; chemical treatment of liquids; custom manufacturing of cell lines for biopharmaceutical production; custom manufacturing of glycosylated pharmaceutical preparations with specific antibody binding

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 1, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, October 1, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 1, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Biologics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIncheon 21987
KR

Trademark Events


Event DateEvent Description
Wednesday, October 1, 2025NEW APPLICATION ENTERED
Wednesday, October 1, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, February 10, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 20, 2026ASSIGNED TO EXAMINER
Saturday, February 21, 2026NON-FINAL ACTION WRITTEN
Saturday, February 21, 2026NON-FINAL ACTION E-MAILED
Saturday, February 21, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 12, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2026TEAS/EMAIL CORRESPONDENCE ENTERED